On August 6, 2020, AMAG Pharmaceuticals, Inc. announced that Brian Piekos was appointed AMAG’s Executive Vice President and Chief Financial Officer, effective as of August 13, 2020. Mr. Piekos had been serving as the Company’s interim Chief Financial Officer since June 8, 2020. Mr. Piekos, age 46, joined AMAG in 2015 and has held a number of senior management positions with the Company. In his role as Chief Financial Officer, he will act as the Company’s principal financial officer and principal accounting officer and oversee the accounting, corporate finance, and investor relations teams. He has more than 20 years of corporate finance experience including strategic planning, financial reporting and capital market activities. Prior to AMAG, he held positions of increasing responsibility at Cubist Pharmaceuticals. Mr. Piekos began his career in investment banking having served as Vice President at Leerink Partners and as an analyst at Needham & Company.